Skip to main content
. Author manuscript; available in PMC: 2012 Oct 6.
Published in final edited form as: J Med Virol. 2011 Oct;83(10):1696–1703. doi: 10.1002/jmv.22194

Table III.

Univariate and multivariate model of HHV-8 shedding rate for persons completing both study arms.

Univariate Multivariate

IRR 95% CI P-value IRR 95% CI P-value

Age 0.95 0.88 1.03 0.22

Ethnicity
Black* 1.23 0.19 8.21 0.83
Peruvian* 2.35 0.45 12.39 0.31
Other* 2.39 0.15 38.90 0.54

 Days when genital HSV detected compared to days when no genital HSV detected 0.97 0.79 1.19 0.75

 CD4 count, for every 100 increase 0.92 0.69 1.22 0.54

 HIV log10 copies/ml, for each log increase 1.78 1.17 2.71 0.01 1.10 0.59 2.04 0.77

  HAART vs. no HAART 0.11 0.03 0.42 0.001 0.13 0.02 0.99 0.05

  Valaciclovir vs. placebo 0.82 0.71 0.95 0.01 0.82 0.71 0.96 0.01

  Famciclovir vs placebo 0.70 0.58 0.84 <0.001 0.70 0.58 0.84 <0.001
*

Compared to white race